Mastering compliance and copyright in healthcare and MedComms
In a recent webinar, Marc McArdle, CLA Customer Success Manager, was joined by Jackie Marchington, Head of Compliance and Ethics…
Macro
-
-
Driving bioscience innovation: How Teesside University empowers industry breakthroughs
The biosciences and healthcare industries are evolving rapidly, demanding innovative solutions and skilled professionals. Professor Vikki Rand, Director of Teesside…
-
JP Morgan 2025: Jazz Pharmaceuticals focusing on oncology pipeline
Bruce Cozadd, the retiring CEO of Jazz Pharmaceuticals, has outlined a developing oncology pipeline at the company. Speaking at the…
-
Study finds restrictive clinical trial criteria excludes Lyme disease patients
New analysis of real-world data from the largest US Lyme disease registry, MyLymeData, has shown that most persistent Lyme disease…
-
Percheron plans to broaden pipeline following avicursen disappointment
Percheron Therapeutics has announced that it will investigate avicursen (ATL1102) in other indications besides Duchenne muscular dystrophy (DMD) following disappointing…
-
Xgene’s non-opioid analgesic reduces pain in Phase IIb trial
Taiwanese pharmaceutical company Xgene Pharmaceutical announced that its non-opioid analgesic drug XG005 has reduced acute pain in patients after surgery…
-
Zepbound will dominate obesity market following SURMOUNT-5 results, says analyst
Following positive results from its SURMOUNT-5 trial, Eli Lilly’s Zepbound (tirzepatide) will surpass Novo Nordisk’s Weogvy (semaglutide) in the obesity…
-
First patient dosed as Marengo’s invikafusp alfa trial expands to Europe
Clinical-stage biotechnology company Marengo Therapeutics has announced that it has dosed the first patient in Phase II of its STARt-001…
-
First blood-stage malaria vaccine ‘a much-needed addition’ – analyst
The RH5.1/Matrix-M blood-stage vaccine could constitute a crucial secondary defence for communities at high risk of malaria infection, including those…
-
APAC leading in Parkinson’s disease clinical trials
The Asia-Pacific (APAC) region is leading in the Parkinson’s disease clinical trial space globally with 44% of trials, according to…
